Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
The purposes of the study is to determine whether blood sugar control is different between
Lantus and a third oral anti-diabetic agent when added to patients who fail a
thiazolidinedione and sulfonylurea or metformin combination.